The inhibition of neutrophil migration by blocking of chemokine receptor CXCR2 or in CXCR2 deficient mice was shown to reduce tumor angiogenesis and growth in B16F10 melanoma [28] and Lewis lung carcinoma mouse models [49]. The gene discussed is CXCR2; the disease is neoplasm.